Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
08/2010
08/11/2010EP2214719A2 Metallofullerene contrast agents
08/11/2010EP1633327B1 Method for improving stability and shelf-life of liposome complexes
08/11/2010EP1320762B1 Method of magnetic resonance investigation of a sample using a nuclear spin polarised mr imaging agent
08/11/2010CN101801420A Ed-B fibronectin as stratification marker for anti-tumor drugs
08/11/2010CN101797391A Disposable bactericidal medical ultrasonic couplant and preparation method thereof
08/11/2010CN101214168B Animal behavior monitoring and analyzing system
08/10/2010US7771962 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle
08/10/2010US7771730 Using immunodiagnostics to detect RNA virus infection
08/10/2010US7771722 Using immunoglobulin specific for beta amyloid protein or sequestering protein to diagnose/ prognose nervous sytem disorders
08/10/2010US7771707 Abuse-deterrent drug formulations
08/10/2010US7771706 Measuring amount of Choline present in tissue adjoining or surrounding cancerous tissue before and after treatment by Magnetic Resonance Spectroscopy (MRS), after administration of angiogenesis inhibitor
08/10/2010US7771705 Radiographic contrasting agents and radio-opaque polymeric materials for medical devices
08/05/2010WO2010088336A1 Solid oral formulations of a pyridopyrimidinone
08/05/2010WO2010087972A2 Il-1 binding proteins
08/05/2010WO2010087477A1 Holding device for an item to be measured, holding device for living organisms and optical measuring device
08/05/2010WO2010086615A1 Luminescent lanthanide complexes
08/05/2010WO2010085876A1 Thylakoids and their functional derivatives, and their uses
08/05/2010WO2010063701A3 In vivo imaging method for parkinson' s disease
08/05/2010WO2010051544A3 Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
08/05/2010WO2009133203A3 In vivo mr imaging with contrast agents comprising a metal-binding protein, polypeptide or peptide
08/05/2010US20100198059 Remotely activated marker
08/05/2010US20100196989 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
08/05/2010US20100196360 Neutrokine-alpha and neutrokine-alpha splice variant
08/05/2010US20100196284 Ultrasound Imaging with Targeted Microbubbles
08/05/2010US20100196283 Method and imaging medium for use in the method
08/05/2010US20100196282 Optical imaging agents
08/05/2010US20100196281 Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent
08/05/2010US20100196280 Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications
08/05/2010US20100196279 Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
08/05/2010US20100196278 Photoacoustic imaging agent
08/05/2010US20100196277 Nanoparticle compositions for controlled delivery of nucleic acids
08/05/2010US20100196276 diagnosing hypothyroidism in a canine via measuring thyroxine levels, administering sialylated recombinant Thyroid Stimulating Hormone (produced by isolated lepidopteran cell), comparing thyroxine levels thereafter; cost efficiency
08/05/2010US20100196275 Methods and products for neutralizing the harmful effects of combustion products
08/05/2010US20100196264 Use of somatostatin analogs in myocardial perfusion imaging
08/05/2010DE102009007152A1 Ultrasound gel, useful in ultrasonic diagnosis, phlebology, pediatrics and tattoo and piercing studios, comprises mondamin, octenisept, lidocaine and carbostesin
08/05/2010DE102008064065B3 Farbstofflösung Dye solution
08/05/2010CA2749966A1 Il-1 binding proteins
08/05/2010CA2749533A1 Solid oral formulations of a pyridopyrimidinone
08/04/2010EP2213672A1 Novel compound having affinity for amyloid
08/04/2010EP2213671A1 Novel compound having affinity for amyloid
08/04/2010EP2213310A1 High frequency ultrasound imaging using contrast agents
08/04/2010EP2211910A2 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof
08/04/2010EP2211897A1 Altered n-cadherin processing in tumor cells by furin and proprotein convertase 5a (pc5a)
08/04/2010EP1711618B1 Methods for detecting markers associated with endometrial disease or phase
08/04/2010CN101795711A chemical linkers and cleavable substrates and conjugates thereof
08/04/2010CN101791414A Multifunctional EPR bio-probe based on magnetic nano particle and application thereof
08/04/2010CN101791413A Anus injecting iodine intestinal tract contrast agent and application thereof in CT virtual colon-proctoscope
08/04/2010CN101132814B A staining composition for staining an ophthalmic membrane
08/03/2010US7767880 Methods of screening agents for activity using teleosts
08/03/2010US7767229 Use of poly diallyamine polymers
08/03/2010US7767219 Drug core encapsulated with multilayer polyelectrolyte shells
08/03/2010US7767201 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same
08/03/2010US7767196 Optimized relaxivity and specificity hepatobiliary MRI contrast agent
08/03/2010US7767195 neurophysiological assay using information obtained from injecting a neural activity blocker, such as tetrodotoxin, into one hippocampus persistently coactivated pyramidal cell in the uninjected hippocampus that initially discharged independently
08/03/2010US7767194 Using cyanine dyes; in situ supplying to tumor cells
07/2010
07/29/2010WO2010085797A2 Arginase inhibitors and methods of use
07/29/2010WO2010085586A1 Secreted phospholipase a2 biomarkers for arthritis
07/29/2010WO2010063491A3 Transport-mediating colloidal pharmaceutical compounds
07/29/2010WO2010063483A9 Active ingredient-peptide construct for extracellular enrichment
07/29/2010WO2010060941A3 Contrast agents
07/29/2010WO2010042512A3 Detection of atherosclerosis using indocyanine green
07/29/2010WO2009078000A8 Imaging dyes and use thereof
07/29/2010US20100191096 Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function
07/29/2010US20100189718 Molecules with extended half-lives, compositions and uses thereof
07/29/2010US20100189660 Methods for the detection of fatty-acylated protein
07/29/2010US20100189659 Diagnostic substance and method for the diagnosis of prostate diseases
07/29/2010US20100189658 Imaging probes
07/29/2010US20100189657 Intramolecularly quenched fluorochrome conjugates and methods of use
07/29/2010US20100189656 Contrast agents
07/29/2010US20100189655 Methods for treating headache
07/29/2010US20100189654 Animal model for evaluating vasomotor response in vivo
07/29/2010US20100189653 Pyrone analogs for therapeutic treatment
07/29/2010US20100189652 Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
07/29/2010US20100189651 Modified antibody compositions, methods of making and using thereof
07/29/2010US20100189650 Near-Infrared Responsive Carbon Nanostructures
07/29/2010US20100189649 Monoclonal antibodies to activated erbb family members and methods of use
07/29/2010US20100189648 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
07/29/2010US20100189646 Carbazole Derivatives as Functional 5-HT6 Ligands
07/29/2010US20100189645 Metal chelators and methods of their use
07/29/2010US20100189644 Arginase inhibitors and methods of use
07/29/2010US20100189643 Drug delivery with stimulus responsive biopolymers
07/29/2010CA2749853A1 Arginase inhibitors and methods of use
07/28/2010EP2209496A2 Multifunctional degradable nanoparticles with control over size and functionalities
07/28/2010CN1833727B Use of Arab gum in setting up animal's model and lowering blood cholestenone
07/28/2010CN1774200B Arrangement and method for the spatially resolved determination of state variables in an examination area
07/28/2010CN101790410A Removal of silica from water soluble compounds by nanofiltration and reverse phase chromatography
07/28/2010CN101790386A Clustered magnetic particles as tracers for magnetic particle imaging
07/28/2010CN101786601A Preparation method of compound nano particle with Fe3O4/CoO core shell structure
07/28/2010CN101785759A Nanoparticle for embedding medicinal Adriamycin as well as preparation method and application thereof
07/28/2010CN101347625B Thrombus target contrast agent of nuclear magnetic resonance and preparation method thereof
07/28/2010CN101249268B Disinfection sterilizing type medical supersonic couplant and method of preparing the same
07/27/2010US7763443 Expression vector comprising nucleotide sequences coding green fluorescent protein for use as reporter molecule in gene expression analysis
07/27/2010US7763234 peptides drugs that are converted into its active form, by cleavage by angiotensin converting enzyme in vivo, for use in the treatment and diagnosis of congestive heart failure, cardiac arrhythmia and other diseases where fibrosis is prominent
07/27/2010US7762957 measuring pancreatic metabolism, characterized by the fact that the increase in 13CO2 in the exhaled breath is determined prior to and following the intravenous application of secretin as well as prior to and following the oral application of a 13C triglyceride
07/22/2010WO2010083154A2 Heterofunctional segment-poly(ethylene glycol) polymers as delivery vehicles
07/22/2010WO2010083107A1 Biocompatible microbubbles to deliver radioactive compounds to tumors, atherosclerotic plaques, joints and other targeted sites
07/22/2010WO2010082634A1 Compound retained in tumor
07/22/2010WO2010062854A3 Methods and compositions for using bleomycin-derivatized microbubbles
07/22/2010WO2010062604A3 Models of thrombotic thrombocytopenic purpura and methods of use thereof
07/22/2010WO2010040772A3 Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 354